Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.php

Latest From CSPC Pharmaceutical Group Limited

Chinese Biotechs Partner Up 18.2-Targeting ADCs Amid Intense Domestic Competition

Following rapid R&D growth in the area, China now has roughly 40 drug candidates targeting Claudin 18.2 across various modalities including monoclonal antibodies, antibody-drug conjugates and bispecific antibodies, with a number of contenders now striking international licensing-out deals in a bid to get ahead of rivals.

China Deals

Local Generics Win Big In China's Latest National Tender

Only four multinationals, including Pfizer, had to make deep cuts to the prices of their off-patent drugs to outbid local generic competitors in China’s seventh round of centralized volume-based procurement. Among the foreign firms that lost out in the bidding, Eisai looks set to be dealt the heaviest blow in terms of market share.

China Pricing Strategies

China's First Biotech M&A Deal In 2022 Signals Busy Season Ahead?

CSPC acquires a little-known Guangzhou biotech to kick-start China's pharma sector consolidation in 2022, a key goal outlined in the country's recent 14th Five-Year Plan.

China Deals

2021 Marked New Era Of Domestic Collaboration in China

Major deals showed an increasing focus on domestic tie-ups while an unsatiable appetite for innovation drove drug firms to actively seek out biotechs for collaboration.

China Scrip Perspectives
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
    • NovaRock Biotherapeutics, Shijiazhuang Pharma Group
    • China Shijiazhuang Pharmaceutical Group Co Ltd
    • Hong Kong Tainuo Pharma Ltd
    • Jiangsu Tainuo Pharmaceutical Co Ltd
    • CSPC Pharmaceutical Group Co., Ltd.
    • JMT-Bio
    • Shanghai Jinmante Biotechnology Co., Ltd.
UsernamePublicRestriction

Register